LIVER

LIVER
84問 • 2024-01-31
  • Julia Skellie
  • 通報

    Antagonist

    Antagonist

    Julia Skellie · 178問 · 2年前

    Antagonist

    Antagonist

    178問 • 2年前
    Julia Skellie

    Monitors

    Monitors

    Julia Skellie · 144問 · 2年前

    Monitors

    Monitors

    144問 • 2年前
    Julia Skellie

    Positioning

    Positioning

    Julia Skellie · 88問 · 2年前

    Positioning

    Positioning

    88問 • 2年前
    Julia Skellie

    arterial vasodilators, peripheral vasodilators, CCB

    arterial vasodilators, peripheral vasodilators, CCB

    Julia Skellie · 122問 · 2年前

    arterial vasodilators, peripheral vasodilators, CCB

    arterial vasodilators, peripheral vasodilators, CCB

    122問 • 2年前
    Julia Skellie

    AntiArrhythmics

    AntiArrhythmics

    Julia Skellie · 70問 · 2年前

    AntiArrhythmics

    AntiArrhythmics

    70問 • 2年前
    Julia Skellie

    just dont forget:

    just dont forget:

    Julia Skellie · 8問 · 2年前

    just dont forget:

    just dont forget:

    8問 • 2年前
    Julia Skellie

    Rspiratory

    Rspiratory

    Julia Skellie · 42問 · 2年前

    Rspiratory

    Rspiratory

    42問 • 2年前
    Julia Skellie

    Monitored and Conscious Sedation

    Monitored and Conscious Sedation

    Julia Skellie · 48問 · 2年前

    Monitored and Conscious Sedation

    Monitored and Conscious Sedation

    48問 • 2年前
    Julia Skellie

    Emergence

    Emergence

    Julia Skellie · 29問 · 2年前

    Emergence

    Emergence

    29問 • 2年前
    Julia Skellie

    PACU

    PACU

    Julia Skellie · 14問 · 2年前

    PACU

    PACU

    14問 • 2年前
    Julia Skellie

    Random

    Random

    Julia Skellie · 19問 · 2年前

    Random

    Random

    19問 • 2年前
    Julia Skellie

    pharm exam 3

    pharm exam 3

    Julia Skellie · 42問 · 2年前

    pharm exam 3

    pharm exam 3

    42問 • 2年前
    Julia Skellie

    Pharm Induction Agents

    Pharm Induction Agents

    Julia Skellie · 58問 · 2年前

    Pharm Induction Agents

    Pharm Induction Agents

    58問 • 2年前
    Julia Skellie

    Laparoscopic Surgery

    Laparoscopic Surgery

    Julia Skellie · 39問 · 2年前

    Laparoscopic Surgery

    Laparoscopic Surgery

    39問 • 2年前
    Julia Skellie

    Hematology Coagulation

    Hematology Coagulation

    Julia Skellie · 66問 · 2年前

    Hematology Coagulation

    Hematology Coagulation

    66問 • 2年前
    Julia Skellie

    ENT

    ENT

    Julia Skellie · 17問 · 2年前

    ENT

    ENT

    17問 • 2年前
    Julia Skellie

    Opioids

    Opioids

    Julia Skellie · 18問 · 2年前

    Opioids

    Opioids

    18問 • 2年前
    Julia Skellie

    MH

    MH

    Julia Skellie · 32問 · 2年前

    MH

    MH

    32問 • 2年前
    Julia Skellie

    NeuroSurg

    NeuroSurg

    Julia Skellie · 20問 · 2年前

    NeuroSurg

    NeuroSurg

    20問 • 2年前
    Julia Skellie

    Burns

    Burns

    Julia Skellie · 89問 · 2年前

    Burns

    Burns

    89問 • 2年前
    Julia Skellie

    Regional

    Regional

    Julia Skellie · 11問 · 2年前

    Regional

    Regional

    11問 • 2年前
    Julia Skellie

    問題一覧

  • 1

    liver rib location innervation fun facts

    7-11 rib right midaxillary line T3-T11 largest organ RUQ blood reservoir

  • 2

    functional unit of liver: how many:

    lobule 50-100K hexagonal in corsssection with center central vein and 6 portal veins hepatocytes circumference the central vein

  • 3

    glissons capsule

    connective tissue covering liver and parts of H arty, P vein and bile ducts

  • 4

    kupffer cells:

    remove bacteria before blood drains into IVC

  • 5

    bile: produced by hepatyocyes and stored in ___________ __________ drain bile > into bile ducts and the bile ducts converge to form the _____________ in the GB the cystic duct and pancreatic duct joint the CHD before emptying into the _______________ the ________________ controls bile flow from the CHD

    gall bladder canaliculi common hepatic duct duodenum sphincter of oddi

  • 6

    lymphatic drains into space of ______ and empties into lypactic duct

    disse

  • 7

    liver receives _____% CO

    30%

  • 8

    portal vein map

    aorta > splancnic organs > portal vein > liver

  • 9

    portal vein % liver blood flow

    75%

  • 10

    portal vein % oxygen content and O2 sat

    50 and lower than hepatic artery

  • 11

    receptors of portal vein

    A1 vasocon D1 vasodilation

  • 12

    portal vein normal pressure and pHTN

    normal 7-10mmHG pHTN 20-20mmHg

  • 13

    hepatic artery map

    aorta > hepatic arty > liver

  • 14

    hepatic arty % liver blood flow

    25

  • 15

    hepatic arty %oxygen content and O2 sat

    50% and higher

  • 16

    receptors of hepatic artery

    A1 vasocon B2 D1 vasodilation

  • 17

    hepatic artery buffer response

    when portal vein decreases flow the hepatic artery compensates by increasing flow by washing out vasodilators (adenosine)

  • 18

    causes decrease hepatic blood flow

    hypoxia, pain, SNS activation> increase in splanchnic vascular resistance hemorrhage > blood diverts elsewhere anesthesia > decrease MAP PPV, increase volume, CHF> increase CVP

  • 19

    hematologist properties of liver

    procoagulants: all clotting facotrs (except for 8) anticoag: antithrombin, protein C, S, Z fibrinolytics: plasminogen thrombopoetin: stimulates plt production

  • 20

    metabolic of liver

    carbs: regulate glucose, clears insulin liver failur: hypoglycemia

  • 21

    liver and proteins:

    AA deamination: proteins> carbs/fats produces ammonia > urea hepatic encephalopathy albumin

  • 22

    lipids and the liver

    triglycerides = energy storage synthesis of: cholesterol phospholipids lipoproteins

  • 23

    liver and bilirubin

    aged RBC >> unconj bilir in spleen >> liver conjugation with glucagon in acid > conj bilir excreted in bile

  • 24

    3 main functions of bile

    1. req for fat and fat soluble vitamin absorption 2. excretion pathway for bilirubin and metabolic products 3. alkalication of duodenum

  • 25

    hepatitis: excretion pathway interruption:

    hemolysis > unconj bilir > neurotoxic and jaundice

  • 26

    hepatitis; vascular; decreased hepatic blood flow will cause what to hepatic extraction ratio

    increase = perfusion depended clearance

  • 27

    hepatitis; valscuar: intrahepatic obstruction of blood flow: 3 dooms

    portal HTN varicies ascites

  • 28

    hepatitis and the spleen

    splenomegaly; plt sequestration; thrombocytopenia

  • 29

    hepatitis and hematologic

    loss of hemostasis decrease: clotting factors, plts anemia: increase bleeding, increase RBC destruction, nutritional def

  • 30

    hepatitis and metabolic

    bio transformation impaired decrease amount and quality of albumin > ascites, edem, altered drug kinetics increase protein bound drugs will have high VOD

  • 31

    drug induced hepatitis’s 5

    Tylenol- consumes livers glutathione NSAIDS ETOH- no fatty acid metabolism and hepatmegly toxins halothene

  • 32

    what is hepatitis

    liver inflammation hepatocellura injury with vary necrosis degree most common cause of liver cancer and trampsoant

  • 33

    chronic hepatitis most commonly

    ETOH hep 3

  • 34

    chronic lobular hepatitis

    recurrent exacerbation of acute inflammation rarely get to cirrhosis

  • 35

    chronic active hepatitis; define clinical and sx

    progressive heptoctye destruction and cirrhosis clinical: mult organ failure, enceph, variceis rupture sx: jaundice, fatigue, throbotyov, neuropathy, myocarditis, PT prolong, arthritis, glomnephritis, low albumin

  • 36

    cirrhosis CNS effects:

    +ammonia +ICP> somnolence and encephalahty impaired BBB> coma neuro transmission alteration > increase uptake of benzos

  • 37

    cirrhosis patients INTOLERANT to: and why

    HYPOXEMIA from anemia and low blood viscosity HYPOVOLEMIA from decrease PRV and increase CO

  • 38

    cirrhosis cardiac: AV shunt limits > less responsive to =

    CO cats

  • 39

    cirrhosis: cell death replaced with ______ and ________ less functional hepatocytes and (increase or decrease) of sinusoids? less blood vessels and more nodules with increase hepatic vascular reisstance and lead to: ________ compensation by: ___________ that bypasss liver and this is called: __________ drugs and toxins like ammonia will stay in liver longer all of this leads to:

    nodules and fibrotic tissue increase sinusoids portal HTN collateral vessels >> portostytemic shunt EXTENSIVE DISORGANIZATION OF LOBULAR STRUCTURE MULTISYSTEM ORGAN FAILURE

  • 40

    cirrhosis and GI: main big star: malabasorbution will leads to _________ low albumin>> ______ and _______ peptic ulcers >> ______ gallstones>> ______ portal HTN >>> ______ and causes this electrolyte imbalance

    reduces esophageal sphincter tone > aspiration > RSI malnutrition bowel edem, less drug bound and more free drug GI bleed jaundice ascites and dilutional hyponatremia

  • 41

    cirrhosis and Pulm: intrapulm AV shunt and pleural effusions>> ________ hypoxia >>> 2,3 DPG >> _______ ascites >> ________ high ammonia >_______ increased circulating vasodilators>> ____

    hypoxemia, R to L shunt, VQ mismatch decrease oxygen affinity for hgb shifts R decrease FRC, compliance > atelectasis hyperventilation impairs HPV

  • 42

    cirrhosis and renal: what happens with RAAS decrease RBF >> increase ADH>> hepatorenal syndrome:

    increase RAAS > increase aldosterone and water retention > hypokalemia, dilutional hyponatremia dilutional hyponatremia relative hypovolemia and ascites cirrhosis + portal htn + ascites = intense renal vasoconstriction; decrease RBF decrease UO with almost no Na+ increase BUN/Cr

  • 43

    how to optimize sx for chronic hepatitis:

    volume oxygen: VQ mismatch and ascites electrolytes heme

  • 44

    chronic hepatitis and sx: how to maintain HBF gas of choice avoid: others:

    ISO - not halothane avoid PEEP normocapnia liberal IVF regional OK if coags ok

  • 45

    hepatotoic drugs and CYP450 inhibitors

    Tylenol halothene amio penicillin and tetracycline

  • 46

    chronic hepatitis and sx: GA what to avoid other

    avoid: splanchnic resistance, light anesthesia , hypoxia, hypercarbia full. stomach, RSI maintain HBF and oxygenation

  • 47

    chronic hepatitis and sx: volatiles

    avoid: high concentration, high flow sevo, halothene, N2O bc of bowel distention and alters splanchnic flow

  • 48

    chronic hepatitis and sx: and regional

    reduces polypharm requirement avoid low BP coags okay? decreases AMIDE local anesthesia metabolism so use ESTERS

  • 49

    chronic hepatitis and sx: IV anesth and metabolism concerns

    small incremental dose impaired metabolism: protein binding high VOD hepatic ext ratios

  • 50

    chronic hepatitis and sx: and muscle relaxants

    reduced biliy excretion: roc risk succ and less pseudo NDNMB may require large initial dose less skeletal mass then less maintence does required good: cis, atricurium

  • 51

    chronic hepatitis and sx: and fluids

    maintain UO crystalloids albumin 25% blood, FFP, cryo, plt, vit K

  • 52

    chronic hepatitis and sx: ventilation what will hypercarbia cause >> high intrathoracic pressure >>

    hypercarbia>> SNS stimuli of splanchnic casvulature and decrease portal hepatic blood flow increase intrthorcic pressure with decreation HBF

  • 53

    ETOH withdrawal: onset: peak:

    onset: 6-8 hours after blood is normal peak: 24-36 hours early signs: tremor, disorientation late: increase SNS, NV, insomnia, agitation tx: alcohol, BB, A2 agonist 2-4 days signs: DTs, seizure, tachy, up or down BP, combative tx: diazepam, BB other tx: vit B (thiamine) and disulfiramin (hepatotoxic)

  • 54

    ETOH withdrawal signs early late 2-4 days

    onset: 6-8 hours after blood is normal peak: 24-36 hours early signs: tremor, disorientation late: increase SNS, NV, insomnia, agitation tx: alcohol, BB, A2 agonist 2-4 days signs: DTs, seizure, tachy, up or down BP, combative tx: diazepam, BB other tx: vit B (thiamine) and disulfiramin (hepatotoxic)

  • 55

    ETOH withdrawal tx of early/late then treatment of 2-4 days

    onset: 6-8 hours after blood is normal peak: 24-36 hours early signs: tremor, disorientation late: increase SNS, NV, insomnia, agitation tx: alcohol, BB, A2 agonist 2-4 days signs: DTs, seizure, tachy, up or down BP, combative tx: diazepam, BB other tx: vit B (thiamine) and disulfiramin (hepatotoxic)

  • 56

    active drunk: MAC will be less or more required

    less

  • 57

    chronic drunk not drunk at moment with do what to MAC

    more MAC req

  • 58

    alcohol: _________ GABA so >> inhibits: _________ impairs: ___________ >>

    potentials GABA so increase effect of benzos inhibit NMDA receptor impaires pharyngeal reflex > aspiration

  • 59

    best indicators of liver function: labs which is more sensitive to acute injury

    PT: 12-14 sec albumin: 2.5-5 bilirubin: 0-11 also: AST/ALT: 10-40 CBC, plt

  • 60

    most common reason for liver transplant

    hep C then ETOH

  • 61

    preop consideration to liver transplant

    blood bank coagupathy for lining if encephalitic then no anti anxiety med do not correct hyponatremia too fast- central pontine

  • 62

    MELD

    predict 90 day mortality facotrs: bilirubin, INR, creatinine

  • 63

    child Pugh

    facors: albumin pt bilirubin ascites encephalotphy

  • 64

    liver transplant: first phase

    preanaheptic

  • 65

    liver transplant: pre-anaheptic:

    incision to cross clamp of portal vein, hepatic artery, IVC RSI CV instability massive transfusion CVP normal then increase to 10 right before clamping careful not give too much fluid to cause dilutional coagulapathy prevent hypothermia

  • 66

    transfusion goals liver transplant:

    hgb 7 plt 40 fib 100 TEG 45

  • 67

    liver transplant: anahepatic:

    removal of native liver to implantation of donor 3 methods: biocaval clamp piggy back venovenous bypass vascular clamping with cause decrease preload and CO (lowest here) no liver function worse coagulpahty, blood loss, lactic acidosis, hypoglycemia

  • 68

    liver transplant: neohepatic

    reperfusion to biliary anastomosis complications: HYPERKALEMIA hypocal cytokine relae Lacie acid embolism debri hypothermia pulmHTN avoid high CVP

  • 69

    good graft function post liver transplant: immediately:

    normal glucose normothermia acid base balance

  • 70

    post reperfusion syndrome: liver transplant

    neohepatic phase hypotension for at least 1 min for first 5 min of reperfusion (under 30% baseline) pressers, correct electrolytes, acid base

  • 71

    postop liver transplant poor graft signs

    hemodynamic instability lack of bile output

  • 72

    postop considerations liver transplant

    poor graft: hemodynamic instability and lack of bile output no epidruel pain PCA anti rejection med- infection risk steroids might req insulin gtt

  • 73

    liver resection surgical risks depend on _________ up to what % can be resected steps:

    preop liver function 75 1. control of vessels 2. parenchymal transection 3. Pringle maneuver- 60-90 min max clamp

  • 74

    total vascular exclusion:

    large resection or tumor in IVC entire area of IVC is clamped risk tearing IVC, VAE

  • 75

    liver resection anesthesia consideration

    vol and CV stability blood loss VAE extubate ?

  • 76

    TIPS

    transjugular intrahepatic portosystemic shunt temporary tx for hepatorenal syndrome bypass portion of hepatic circulation by shunting blood from port vein to hepatic vein will decrease portal pressure, less bleed from esophageal varies, and less ascites risk: hemorrhage

  • 77

    cholesystokinin:

    stimulates GB to contract

  • 78

    gallstone risk factors

    obesity increase age rapid wt loss prego women>men

  • 79

    gallstone signs

    leukoytosis fever RUQ pain muphys sign: worst with inspiration

  • 80

    gallstone obstruction to cystic duct:

    GB distention edema perf risk jaundice

  • 81

    gallstone obstruction to common hepatic duct

    cholesystis jaundice pancreatitis peritonitis

  • 82

    choledochlithiasis: what and tx

    gallstone in commonheptic duct and ERCP

  • 83

    cholelithiaiss and tx

    stones in gall bladder and cholecystectomy

  • 84

    cholecycsemty/gall bladder procudures; anesthesia consideration

    laposcopic avoid N2O if liver dysfunction use cisatricurium avoid opioids bc sphincter of oddi relax sphincter: glucagon, NGT, atropine